SynthesisBMC nephrology2020

Rituximab therapy for focal segmental glomerulosclerosis and minimal change disease in adults: a systematic review and meta-analysis.

Panupong Hansrivijit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.